Whole blood mitochondrial copy number in clinical populations with mood disorders: a meta-analysis.
Cali A CalarcoSwarnapali M KeppetipolaGautam KumarAndrea Goldstein ShipperMary Kay LoboPublished in: bioRxiv : the preprint server for biology (2023)
Together our data suggest whole blood/leukocyte mtDNAcn may be a useful biomarker for mood disorders, with MDD and BD Type II associated with higher mtDNAcn, and BD Type I associated with lower mtDNAcn. Further study of blood mtDNAcn could predict downstream health outcomes or treatment responsivity in individuals with mood disorders.